1. Home
  2. GOVX vs CHR Comparison

GOVX vs CHR Comparison

Compare GOVX & CHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$0.17

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

N/A

Current Price

$1.42

Market Cap

3.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GOVX
CHR
Founded
2001
2016
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.6M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
GOVX
CHR
Price
$0.17
$1.42
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 111.0K
87.7K
Earning Date
11-12-2026
07-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.06
Revenue
★ $2,489,145.00
N/A
Revenue This Year
N/A
$105.44
Revenue Next Year
N/A
$30.02
P/E Ratio
★ N/A
$22.69
Revenue Growth
N/A
★ N/A
52 Week Low
$0.17
$0.03
52 Week High
$1,425.00
$2.95

Technical Indicators

Market Signals
Indicator
GOVX
CHR
Relative Strength Index (RSI) 8.96 47.05
Support Level N/A $0.73
Resistance Level $8.64 $1.79
Average True Range (ATR) 0.16 0.12
MACD -0.15 0.01
Stochastic Oscillator 0.00 42.19

Price Performance

Historical Comparison
GOVX
CHR

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

Share on Social Networks: